French medtech making graphene-based wearable and disposable biosensors for monitoring and diagnosis.
| Date | Round | Amount |
|---|---|---|
| Feb 2021 | Seed French medtech Grapheal raised €1.9m in equity and non-dilutive funding, with seed financing from Novalis Biotech and Bpifrance, to develop its graphene biosensors. | $2.3M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.